The study sample comprised 50 female RA patients aged 51.50 ± 3.94 years, 84% of whom were diagnosed within the preceding 5 years, and 95% and 92% were positive for rheumatoid factor (RF) and anti-cyclic citrulline peptide antibodies (ACPA), respectively. Here, PRTN3 is linked to rheumatoid arthritis.